Other biomarkers that are altered in men with obesity include pro-inflammatory cytokines [47], insulin [43], and oxidative stress biomarkers [48], which have been hypothesised to increase prostate cancer risk [49, 50]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.